VENZIOV Trademark
VENZIOV is a USPTO trademark filed by Genmab A/S. Status: Cancelled.
Prosecution Summary
Trademark Summary
VENZIOV is registered for pharmaceutical preparations and substances for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases. The application was filed on June 21, 2007 and the registration issued on July 15, 2008, but the current status is that the U.S. registration has been cancelled because the international registration was cancelled in whole or in part. The owner/registrant is Genmab A/S. The prior status information includes a cancellation reference tied to “DEATH OF IR” for the earlier registration.
An opposition has been filed by Keth E. Danish (Hiscock & Barclay, LLP) against Johnso
Trademark Facts
| Mark | VENZIOV |
|---|---|
| Serial Number | 79040512 |
| Registration Number | 3468166 |
| Status | Cancelled |
| Filing Date | 2007-06-21 |
| Registration Date | 2008-07-15 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Genmab A/S |
| Attorney of Record | RALPH H LANE |
| Prosecution Events | 34 |
| Latest Event | DENC on 2018-01-11 |